Search
Close this search box.

[:pb]4H-1,3-Benzothiazin-4-one a promising class against MDR/XDR-TB[:]

[:pb]Authors: De Souza, M. V. N.; Nogueira, T. C. M.
Source: Current Topics in Medicinal Chemistry, v. 19, p. 567-578, 2019
Publisher: Bentham Science


Abstract

Nowadays, tuberculosis (TB) is an important global public health problem, being responsible for millions of TB-related deaths worldwide. Due to the increased number of cases and resistance of Mycobacterium tuberculosis to all drugs used for the treatment of this disease, we desperately need new drugs and strategies that could reduce treatment time with fewer side effects, reduced cost and highly active drugs against resistant strains and latent disease. Considering that, 4H-1,3-benzothiazin-4-one is a promising class of antimycobacterial agents in special against TB-resistant strains being the aim of this review the discussion of different aspects of this chemical class such as synthesis, mechanism of action, medicinal chemistry and combination with other drugs.


Keywords: tuberculosis, drugs, 4H-1, 3-benzothiazin-4-one, synthesis, mycobacterium tuberculosis, multi drug resistant

Document Type: Review Article

DOI: 10.2174/1568026619666190305130809

Publication date: Março de 2019[:]

Compartilhar publicação

Facebook
Twitter
Email
LinkedIn
WhatsApp

Deixe seu comentário

Compartilhar

Sobre a SSCDT

Nosso grupo de pesquisa está situado em Farmanguinhos e atualmente é o maior laboratório farmacêutico oficial vinculado ao Ministério da Saúde. Farmanguinhos produz mais de um bilhão de medicamentos por ano para os programas estratégicos do Governo Federal, além de atender demandas emergenciais no Brasil e no exterior.

posts Recentes